🔗 Share this article

A shadow economy for unapproved weight-loss medications is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts privately for source information, while also obtaining promotional offers.

Active Commerce on Messaging Platforms

Separately, a robust trade exists on messaging services, where communities with thousands of participants share comparison photos, injection guides and claims of next-day UK delivery. Sellers market the drug there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could lead to individuals injecting products of unknown origin.

Some experts said the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be marketed or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer regulations, risking fines, prosecution or prison.

Service Reaction and Material Elimination

Based on TikTok, the service has removed problematic material and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the platform safe and investing in strengthening compliance measures.

Digital Marketplace Activities

Investigations also found groups with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, filled with photos of weight loss, positive reviews and step-by-step instructions for preparing or injecting at residence.

Within moments of joining one group, a seller posted WhatsApp details, where most purchases take place. The seller sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. None asked about weight, health issues or previous experience.

Product Details and Costs

Within these groups, messages show black plastic packages with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at residence with sterile water, or pre-filled pens typically sold at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give contradictory answers ranging from a few weeks to “depends on your body”.

Service Moderation and Safety Actions

A spokesperson for the messaging service said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“Individuals are injecting substances they cannot confirm. Although the research behind this drug is sound, these online versions may not include what they advertise,” stated Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, patients are using social media. But counterfeit injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has already encountered individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Statement

A representative from Eli Lilly stated the substance was in phase 3 research studies and had not been evaluated or approved by any government authority globally. “Therefore at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet authorized … may expose patients to potentially serious health risks”.